Use of Systemic Glucocorticoids and Risk of Prostate Adenocarcinoma: Evidence From a Danish Population‐Based Case–Control Study

ABSTRACT Background Glucocorticoids may promote prostate cancer by reducing apoptosis and the immune response, or prevent it by reducing inflammation, inhibiting androgens, and limiting cell proliferation. However, epidemiological evidence is limited. Thus, this study aimed to assess the association...

全面介绍

书目详细资料

Principais autores:	Elea Olivier, Blánaid Hicks, Morten Olesen, Agnès Fournier, Gianluca Severi, Anton Pottegård, Manon Cairat
格式:	Artigo
语言:	Inglês
出版:	Wiley 2025-08-01
丛编:	Cancer Medicine
主题:	Danish registries glucocorticoids pharmacoepidemiology prostate cancer
在线阅读:	https://doi.org/10.1002/cam4.71110
标签:	添加标签 没有标签, 成为第一个标记此记录!